L.A. Baxter-Lowe

Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High-Resolution Rather Than the Antigen Level?

René J. Duquesnoy, Malek Kamoun, L.A. Baxter-Lowe et al. · American Journal of Transplantation · 2015 · 85 citations · Full text

Life Sciences, Immunology, Immunogenetics +16

Antibody-Mediated Rejection of a Pancreas Allograft

Marc L. Melcher, Jean L. Olson, L.A. Baxter-Lowe et al. · American Journal of Transplantation · 2006 · 69 citations

Life Sciences, Immunology, Surgery +14

THE PREDICTIVE VALUE OF HLA-DR OLIGOTYPING FOR MLC RESPONSES

L.A. Baxter-Lowe, DAVID D. ECKELS, Robert Ash et al. · Transplantation · 1992 · 44 citations

Life Sciences, Hematology, Immunology +17

A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents

Jan Styczyński, B. Tallamy, Ian M. Waxman et al. · Bone Marrow Transplantation · 2010 · 35 citations

Medicine, Hematology, Chemotherapy +15

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1

Katharina Fleischhauer, Marcelo Fernández-Viña, T Wang et al. · Bone Marrow Transplantation · 2014 · 32 citations · Full text

Life Sciences, Hematology, Immunology +16